Texas Instruments Incorporated, a leading entity in the semiconductor design and manufacturing sector, recently closed its trading session at $179.42 per share on December 11, 2025. The company, which operates within the Information Technology sector, specifically in the Semiconductors & Semiconductor Equipment industry, is publicly traded on the Nasdaq under the ticker symbol TXN.
Throughout the year, Texas Instruments’ share price has experienced significant fluctuations, with a 52-week range spanning from a low of $139.95 on April 10, 2025, to a high of $221.69 on July 10, 2025. As of the latest trading session, the stock is approximately 28% below its peak value, indicating a moderate range in its recent performance.
The company’s market capitalization stands at $163.12 billion, reflecting its substantial presence in the global semiconductor market. Texas Instruments is renowned for its specialization in analog integrated circuits (ICs) and embedded processors, catering to a diverse array of customers worldwide. This specialization underscores its role as a pivotal player in the semiconductor industry.
Financially, Texas Instruments exhibits a mature earnings profile, as evidenced by its valuation multiples. The price-to-earnings (P/E) ratio is currently 33.14, while the price-to-book (P/B) ratio is 9.93. These figures suggest that investors are willing to pay a premium for the company’s earnings and book value, consistent with its reputation as a high-margin, stable cash-generating entity.
In recent developments, Texas Instruments has been linked to a broader industry lawsuit concerning technology export controls, as reported on December 10, 2025. This situation highlights the regulatory scrutiny faced by the company regarding its products, reflecting the broader challenges within the semiconductor industry related to compliance and export regulations.
Overall, Texas Instruments maintains a strong position within the semiconductor sector, characterized by its robust financial metrics and strategic focus on high-margin products. Despite the regulatory challenges, the company’s valuation metrics indicate a premium relative to its earnings and book value, with no significant aggressive price movements observed in the recent trading period.
